A. Kleinfranke et Fa. Anderer, IL-12-MEDIATED ACTIVATION OF MHC-UNRESTRICTED CYTOTOXICITY OF HUMAN PBMC SUBPOPULATIONS - SYNERGIC ACTION OF A PLANT RHAMNOGALACTURONAN, Anticancer research, 15(6B), 1995, pp. 2511-2516
IL-12 mediated activation of human MHC-unrestricted cytotoxicity was s
tudied with freshly isolated, highly enriched CD56(+)CD3(-) NK cells (
95-98%), monocytes/macrophages (90-95%) and CD3(+)T cells (95-98%). Ac
tivation of NK cell cytotoxicity and monocyte cytotoxicity by IL-12 we
re independent of exogenous IL-2 and IFN gamma. Activation of CD3(+)T
cells to MHC-unrestricted cytotoxicity required coactivation by anti-C
D3 antibody. The enhanced cytotoxicities were directed against NK-sens
itive as well as NK-resistant target cells and coincided with enhancem
ent of effector cell/target cell conjugate formation. The specific cyt
otoxicity of all three activated effector cell populations was further
increased in the presence of rhamnogalacturonan. These increases were
based on an additional increase of effector cell/target cell conjugat
e formation that is based on rhamnogalacturonan-mediated bridging betw
een effector cells and target cells. Simultaneous enhancement of cytot
oxicity indicates involvement of receptors on effector cells cross-rea
cting with acetylrhamnose (6-deoxymannose) that might play an importan
t role in human MHC-unrestricted cytotoxicity against tumor cells.